{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:86002"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:86002","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Optimisation of CCR7-based cellular models for future use in drug development programmes","abstract":"C-C Chemokine receptor 7 (CCR7) is a cell surface receptor expressed on a range of immune cells, where it plays a critical role in mediating cell migration, chemotaxis, and immune homeostasis through interactions with its two specific ligands, CCL19 and CCL21. Emerging evidence has demonstrated that cancer cells can exploit CCR7 expression to hijack its natural mechanisms, promoting the metastatic dissemination of malignant cells throughout the body. While CCR7 has been identified as a promising therapeutic target, it also presents significant challenges as targeting this receptor could disrupt immune function and lead to adverse effects, including chronic inflammation and autoimmune diseases. In this study, CCR7 is evaluated as a potential biomarker in oncology by analysing its expression and functional role across selected cancer models, whilst simultaneously attempting to establish a transient and validated CCR7-expressing cell-based system to support future high-throughput drug screening efforts. These findings provide insights into the oncogenic role of CCR7 and establish a platform for targeted therapeutic discovery, while also addressing the biological implications of modulating this receptor.","abstract_html":"C-C Chemokine receptor 7 (CCR7) is a cell surface receptor expressed on a range of immune cells, where it plays a critical role in mediating cell migration, chemotaxis, and immune homeostasis through interactions with its two specific ligands, CCL19 and CCL21. Emerging evidence has demonstrated that cancer cells can exploit CCR7 expression to hijack its natural mechanisms, promoting the metastatic dissemination of malignant cells throughout the body. While CCR7 has been identified as a promising therapeutic target, it also presents significant challenges as targeting this receptor could disrupt immune function and lead to adverse effects, including chronic inflammation and autoimmune diseases. In this study, CCR7 is evaluated as a potential biomarker in oncology by analysing its expression and functional role across selected cancer models, whilst simultaneously attempting to establish a transient and validated CCR7-expressing cell-based system to support future high-throughput drug screening efforts. These findings provide insights into the oncogenic role of CCR7 and establish a platform for targeted therapeutic discovery, while also addressing the biological implications of modulating this receptor.","abstract_has_math":false,"creators":["Pilgrim, Emily Nicole"],"institution":"University of Glasgow","degree_name":null,"degree_level":"MSc(R)","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-19T08:37:41Z","subjects":["R Medicine (General)","RC Internal medicine"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.86002","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.86002","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":"https://theses.gla.ac.uk/86002/1/2026PilgrimMSc%28R%29.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A86002","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Pilgrim, Emily Nicole"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/86002/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["MSc(R)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["R Medicine (General)","RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.86002"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/86002/1/2026PilgrimMSc%28R%29.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["C-C Chemokine receptor 7 (CCR7) is a cell surface receptor expressed on a range of immune cells, where it plays a critical role in mediating cell migration, chemotaxis, and immune homeostasis through interactions with its two specific ligands, CCL19 and CCL21. Emerging evidence has demonstrated that cancer cells can exploit CCR7 expression to hijack its natural mechanisms, promoting the metastatic dissemination of malignant cells throughout the body. While CCR7 has been identified as a promising therapeutic target, it also presents significant challenges as targeting this receptor could disrupt immune function and lead to adverse effects, including chronic inflammation and autoimmune diseases. In this study, CCR7 is evaluated as a potential biomarker in oncology by analysing its expression and functional role across selected cancer models, whilst simultaneously attempting to establish a transient and validated CCR7-expressing cell-based system to support future high-throughput drug screening efforts. These findings provide insights into the oncogenic role of CCR7 and establish a platform for targeted therapeutic discovery, while also addressing the biological implications of modulating this receptor."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Optimisation of CCR7-based cellular models for future use in drug development programmes"]}]}],"canonical_facts":{"dc:creator":["Pilgrim, Emily Nicole"],"dc:date":["2026"],"dc:date.issued":["2026"],"dc:description.abstract":["C-C Chemokine receptor 7 (CCR7) is a cell surface receptor expressed on a range of immune cells, where it plays a critical role in mediating cell migration, chemotaxis, and immune homeostasis through interactions with its two specific ligands, CCL19 and CCL21. Emerging evidence has demonstrated that cancer cells can exploit CCR7 expression to hijack its natural mechanisms, promoting the metastatic dissemination of malignant cells throughout the body. While CCR7 has been identified as a promising therapeutic target, it also presents significant challenges as targeting this receptor could disrupt immune function and lead to adverse effects, including chronic inflammation and autoimmune diseases. In this study, CCR7 is evaluated as a potential biomarker in oncology by analysing its expression and functional role across selected cancer models, whilst simultaneously attempting to establish a transient and validated CCR7-expressing cell-based system to support future high-throughput drug screening efforts. These findings provide insights into the oncogenic role of CCR7 and establish a platform for targeted therapeutic discovery, while also addressing the biological implications of modulating this receptor."],"dc:format":["pdf"],"dc:identifier.doi":["10.5525/gla.thesis.86002"],"dc:identifier.uri":["https://theses.gla.ac.uk/86002/1/2026PilgrimMSc%28R%29.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/86002/"],"dc:subject":["R Medicine (General)","RC Internal medicine"],"dcterms:accessrights":["public"],"dc:title":["Optimisation of CCR7-based cellular models for future use in drug development programmes"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["MSc(R)"]},"updated_at":"2026-11-19T08:37:41Z"}